| 产品名称： | pBL540A |
|---|---|
| 商品货号： | TS191762 |
| Designations： | pBL540A |
| Species： | Human herpesvirus 1, Herpes simplex virus 1 |
| Depositors： | New York State Department of Health, E Paoletti, New York State Department of Health |
| Applications： | It is recommended that TS191762 be used instead of ATCC 39734. |
| Vector： | Construct size (kb): 19.39999961853027 |
| Insert： | DNA: genomic Insert lengths(kb): 15.0 Gene product: glycoprotein gD gD |
| Insert Size (kb)： | 15.0 |
| Media： | ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Shipping Information： | Distributed: freeze-dried |
| Comments： | Restriction digests of the clone give the following sizes (kb): EcoRI--15.0, 4.4; SacI--12.0, 3.0, 2.3, 2.0; BamHI--9.0, 6.5, 2.3, 2.0; HindIII--8.8, 6.5, 4.7. This insert contains SstI (SacI) and HindIII sites. A new deposit was made for this clone. It is recommended that TS191762 be used instead of ATCC 39734. The complete coding region for gD is contained in a 2.9 kb SstI (SacI) fragment. |
| Classification： | Herpesviridae, Simplexvirus |
| References： | Paoletti E, Panicali D. Modified vaccinia virus. US Patent 4,603,112 dated Jul 29 1986 Paoletti E, Panicali D. Method for immunizing animals with synthetically modified vaccinia virus. US Patent 4,722,848 dated Feb 2 1988 Panicali D, et al. Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus. J. Virol. 37: 1000-1010, 1981. PubMed: 6262520 |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | pBL540A |
|---|---|
| 商品货号： | TS191762 |
| Designations： | pBL540A |
| Species： | Human herpesvirus 1, Herpes simplex virus 1 |
| Depositors： | New York State Department of Health, E Paoletti, New York State Department of Health |
| Applications： | It is recommended that TS191762 be used instead of ATCC 39734. |
| Vector： | Construct size (kb): 19.39999961853027 |
| Insert： | DNA: genomic Insert lengths(kb): 15.0 Gene product: glycoprotein gD gD |
| Insert Size (kb)： | 15.0 |
| Media： | ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Shipping Information： | Distributed: freeze-dried |
| Comments： | Restriction digests of the clone give the following sizes (kb): EcoRI--15.0, 4.4; SacI--12.0, 3.0, 2.3, 2.0; BamHI--9.0, 6.5, 2.3, 2.0; HindIII--8.8, 6.5, 4.7. This insert contains SstI (SacI) and HindIII sites. A new deposit was made for this clone. It is recommended that TS191762 be used instead of ATCC 39734. The complete coding region for gD is contained in a 2.9 kb SstI (SacI) fragment. |
| Classification： | Herpesviridae, Simplexvirus |
| References： | Paoletti E, Panicali D. Modified vaccinia virus. US Patent 4,603,112 dated Jul 29 1986 Paoletti E, Panicali D. Method for immunizing animals with synthetically modified vaccinia virus. US Patent 4,722,848 dated Feb 2 1988 Panicali D, et al. Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus. J. Virol. 37: 1000-1010, 1981. PubMed: 6262520 |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
